<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">PIRBUTEROL ACETATE</span><br/>(pir-bu'ter-ol)<br/><span class="topboxtradename">Maxair<br/></span><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">beta-adrenergic agonist (sympathomimetic)</span>; <span class="classification">bronchodilator</span><br/><b>Prototype: </b>Albuterol<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.2 mg aerosol</p>
<h1><a name="action">Actions</a></h1>
<p>Exhibits preferential effect on beta<sub>2</sub>-adrenergic receptors compared with isoproterenol and, consequently, a lengthened duration of action. Stimulation of beta<sub>2</sub>-adrenoreceptors relaxes bronchospasm and increases ciliary motion. Activates adenyl cyclase, the enzyme that catalyzes the
         conversion of ATP to cyclic adenosine monophosphate (cAMP).
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Increased cAMP is associated with relaxation of bronchial smooth muscle and inhibition of the release of histamine and other
         mediators of hypersensitivity from mast cells.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Prevention and reversal of bronchospasm associated with asthma.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to pirbuterol or any other adrenergic agent such as epinephrine, albuterol, or isoproterenol. Pregnancy (category
         C), lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Heart disease, irregular heartbeat; high blood pressure, history of stroke or seizures; diabetes; Parkinson's disease; thyroid
         disease; prostate disease; glaucoma. Safety and effectiveness in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Asthma</span><br/><span class="rdage">Adult/</span><span class="rdage">Child:</span> <span class="rdroute">Inhaled</span> <i>&gt;12 y,</i> 2 inhalations (0.4 mg) q6h (max: 12 inhalations/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Inhalation</span><br/><ul>
<li>Shake inhaler canister well immediately before using.</li>
<li>Direct patient to exhale deeply, loosely close lips around mouthpiece, then inhale slowly and deeply through mouthpiece while
            pressing top of canister.
         </li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Nervousness, headache, dizziness, tremor. <span class="typehead">CV:</span> Palpitations, tachycardia. <span class="typehead">GI:</span> Dry mouth, nausea, glossitis, abdominal pain, cramps, anorexia, diarrhea, stomatitis. <span class="typehead">Other:</span> Cough, tolerance. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span> <b>Epinephrine</b> and other <span class="classification">sympathomimetic bronchodilators</span> may have additive effects. <span class="classification">beta blockers</span> may antagonize the effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Onset:</span> 5 min. <span class="typehead">Peak:</span> 30 min.  <span class="typehead">Duration:</span> 34 h. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Eliminated by kidneys. <span class="typehead">Half-Life:</span> 23 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor arterial blood gases and pulmonary functions periodically.</li>
<li>Monitor vital signs. Report tachycardia, palpitations, and hypertension or hypotension.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Learn proper technique for using the inhaler.</li>
<li>Report palpitations, chest pain, nervousness, tremors, or other bothersome adverse effects promptly to physician.</li>
<li>Contact physician immediately if symptoms of asthma worsen or you do not respond to the usual dose.</li>
<li>Adhere rigidly to dosing directions and contact physician if breathing difficulty persists.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>